Allogene Therapeutics所有资讯

Allogene Therapeutics | 4：持股变动声明-高管 MOORE TIMOTHY L.

04/24 16:24 (美东)

Allogene Therapeutics | 4：持股变动声明-高管 Chang David D

03/18 20:16 (美东)

Allogene Therapeutics | 4：持股变动声明-高管 Parker Geoffrey M.

03/06 21:55 (美东)

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Arie Belldegrun, M.D.(5.8%),Bellco Legacy IV, LLC(2.8%)等

02/14 17:33 (美东)

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-David Chang, M.D., Ph.D.(5.8%),Chang 2006 Family Trust(0.7%)等

02/14 16:39 (美东)

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(5.37%)

02/13 17:09 (美东)

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

02/09 08:40 (美东)

Allogene Therapeutics | 4：持股变动声明-高管 MOORE TIMOTHY L.

01/31 17:58 (美东)

Allogene Therapeutics | 4：持股变动声明-高管 Douglas Earl Martin

01/31 17:58 (美东)

Allogene Therapeutics | 4：持股变动声明-高管 Parker Geoffrey M.

01/31 17:54 (美东)

Allogene Therapeutics | 4：持股变动声明-董事 Belldegrun Arie

01/31 17:54 (美东)

Allogene Therapeutics | 4：持股变动声明-高管 Roberts Zachary

01/31 17:49 (美东)

Allogene Therapeutics | 4：持股变动声明-高管 Chang David D

01/31 17:43 (美东)

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(5.9%)

01/29 17:34 (美东)

Allogene Therapeutics | 4：持股变动声明-高管 Roberts Zachary

01/24 17:31 (美东)

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(1.44%)

01/23 00:00 (美东)

Allogene Therapeutics | 4：持股变动声明-董事 MESSEMER DEBORAH M.

2023/12/20 16:26 (美东)

Allogene Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Pfizer Inc. (“Pfizer”)(13.14%)

2023/10/25 17:29 (美东)

Allogene Therapeutics | 4：持股变动声明-首席财务官 Parker Geoffrey M.

2023/10/17 17:02 (美东)

Allogene Therapeutics | 3：首次持股声明-首席财务官 Parker Geoffrey M.

2023/10/16 19:25 (美东)